Acuitas Investments’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Acuitas Investments’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,960	Closed	-$162K	–	120
2023 Q2	$162K	Buy	+41,960	New	+$154K	0.09%	98

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

Acuitas Investments's DBTX Position: Q3 2023 in Review

Acuitas Investments sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 41,960 shares — an estimated $162K sold.

Acuitas Investments first reported a position in DBTX in Q2 2023 and held it in 1 quarter. The position peaked at $162K in Q2 2023. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Acuitas Investments reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Acuitas Investments sold 41,960 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $162K.
Acuitas Investments first reported a position in Decibel Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Acuitas Investments's Decibel Therapeutics, Inc. Common Stock position peaked at $162K in Q2 2023.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Acuitas Investments's 13F filing for Q3 2023, filed 27 Oct 2023.